Loading ...

Defining Immune Tolerance in ANCA-associated Vasculitis

(

AVATARS

)

ITN Protocol #:

ITN051AI

Branded Name:

AVATARS

ClinicalTrials.Gov ID:

NCT01934504

Treatment Protocol #:

Therapeutic Area:

Autoimmune Disease

Current Status:

Terminated

Summary:

Defining Immune Tolerance in ANCA-associated Vasculitis

Clinical Operations Manager

ITN Biologist

ITN Biostat

ITN Clinical Trial Physician

NIAID Project Manager

Rho Data Manager

Rho Scientist

Study Personnel:

Protocol Chair

Patti Tostaptosta@immunetolerance.org

Work: 

415-353-4421

Protocol Chair

Kristina Harris, PhDkharris@immunetolerance.org

Work: 

240-235-6154

Protocol Chair

Noha Lim, PhDnlim@immunetolerance.org

Work: 

240-235-6151

Protocol Chair

Nadia Tchaontchao@immunetolerance.org

Work: 

415-353-4414

Protocol Chair

Susan Boohersusan.booher@nih.gov

Work: 

240-627-3481

Protocol Chair

Reginald WilliamsReginald_Williams@RhoWorld.com

Work: 

919-595-6318

Protocol Chair

James Rochon, PhDjames_rochon@rhoworld.com

Work: 

919-595-6857